AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARROWHEAD PHARMACEUTICALS, INC. Director's Dealing 2010

Nov 19, 2010

31071_dirs_2010-11-19_5d2bcd76-a800-4e70-8e76-e57702775737.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2010-08-18

Reporting Person: Ferrari Mauro (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	19510	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option granted 01/18/2008	$2.87	2018-01-18	Common Stock (54688)		Direct
Stock Option granted 09/01/2010	$0.96	2020-09-01	Common Stock (200000)		Direct

Footnotes

F1: Vested 9,396 shares on 07/18/2008, then vested 1,562 shares monthly until 08/18/2010 when Dr. Ferrari joined the Arrowhead Board of Directors.